US expert panel endorses Johnson & Johnson's one-dose COVID-19 vaccine; FDA will make final decision soon. By Associated Press | Feb. 26, 2021, at 5:04 p.m. Save More US Expert Panel Endorses Johnson & Johnson'
A second dose of the vaccine more than doubled the amounts of neutralizing antibodies, the results showed.It will be results from phase 3 clinical trials involving 45,000 participants that determine whether a single dose or two doses actually create lasting immune protection against COVID-19....
A possible third coronavirus vaccine could be on the way in the U.S. as the nation ramps up immunizations. Nearly 34 million Americans have had at least one COVID shot so far. Meg Oliver reports.Featured 2025 PGA Championship Leaderboard 2025 Preakness predictions, odds 2025 NBA Play...
However, it is not yet clear if one dose of the vaccine is enough to prevent breakthrough infections compared to two doses. Using data from Optum deidentified COVID‐19 Electronic Health Record (EHR) data set, we assessed breakthrough infection risks in individuals previously infected, ...
Thanks to investment from China, the nation decided to embark on a joint project to build a factory to produce the vaccine in Serbia. The work is under way on the outskirts of Belgrade and the first batches should leave the factory gates by the summer of 2022. ...
WHO Vaccine Advisory Group Endorses Another COVID-19 Booster Shot at 6 Months for Some “We're monitoring it because it has potential changes that we need to keep a good eye out on,” Maria Van Kerkhove, WHO’s COVID-19 technical lead, said at a press conference. The strai...
91.7% of the target population have received at least one dose of the COVID vaccine and 37.5% are now fully vaccinated
Nearly 60% of those working in a large healthcare system expressed their intent to roll up their sleeves to receive the COVID-19 vaccine, but about one third were unsure of doing so. Moreover, 54% of direct care providers indicated that they would take the vaccine if offered, compared wi...
Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates if a report of a patient with a serious side effect is linked to the shot.
An Israeli woman receives her third dose of the coronavirus disease (COVID-19) vaccine, in Jerusalem, October 3, 2021. Photo by REUTERS/Ronen Zvulun REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Acces...